Sponsor

King Faisal Specialist Hospital & Research Center

Clinical research sponsor

Published trials21
Recruiting shown2
Roles2
SourceClinicalTrials.gov

Clinical trials

21 shown
Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast CancerNCT07844473 · lead sponsor · 2026-07-24
RECRUITING
This Study Aims to Compare Asthma Control in Children Monitored With FeNO Against a Historical Cohort Without FeNO. Secondary Objectives Include Evaluating Associations Between FeNO Levels, ACT/C-ACT Scores, Eosinophil Counts, FEV1%, ICS Adherence, and Exacerbation Frequency.NCT07788534 · lead sponsor · 2025-11-12
RECRUITING
The Impact of Type 2 Diabetes Mellitus on Cardiovascular Events in Saudi Arabia Now and FutureNCT06674161 · lead sponsor · 2024-11-30
NOT_YET_RECRUITING
Degludec Insulin Use in Critically Ill PatientsNCT06056167 · lead sponsor · 2023-05-17
COMPLETED
Somatostatin in Living Donor Liver TransplantationNCT04107428 · lead sponsor · 2019-12-01
UNKNOWN
Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer PatientsNCT02628132 · lead sponsor · 2016-11-01
COMPLETED
Optic Nerve Sheath Diameter as a Screening Test for Increased Intracranial PressureNCT02338284 · lead sponsor · 2014-10-01
UNKNOWN
Does Vitamin D Improve Glycemic Control in Type II DM?NCT01170442 · lead sponsor · 2011-12-01
TERMINATED
Does Vitamin D Reduce Risk of Developing Type II DM in High Risk IndividualsNCT01170468 · lead sponsor · 2011-12-01
TERMINATED
Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast CancerNCT01530607 · lead sponsor · 2009-11-01
COMPLETED
Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast caNCT00944424 · lead sponsor · 2009-07-01
UNKNOWN
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast CancerNCT01311037 · lead sponsor · 2009-01-01
UNKNOWN
Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902)NCT00544505 · lead sponsor · 2007-09-01
UNKNOWN
Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast CancerNCT00538330 · lead sponsor · 2007-09-01
UNKNOWN
Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast CancerNCT00538395 · lead sponsor · 2007-09-01
UNKNOWN
Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast CancerNCT00538525 · lead sponsor · 2007-09-01
COMPLETED
Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast CancerNCT00535509 · lead sponsor · 2007-06-01
COMPLETED
Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to PresentNCT00534755 · lead sponsor · 2005-06-01
COMPLETED
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung CancerNCT00540280 · lead sponsor · 2003-10-01
SUSPENDED
Non-Invasive MASLD Diagnosis & T2D Remission BiomarkersNCT07172997 · collaborator · 2025-01-01
ACTIVE_NOT_RECRUITING
Echocardiographic Assessment and CLInical imPlication of Functional tricuSpid rEgurgitation in Heart Failure With Reduced or Preserved Ejection FractionNCT05209919 · collaborator · 2021-11-11
UNKNOWN

Sponsor roles

lead sponsor19
collaborator2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.